1. Home
  2. EXLS vs RGEN Comparison

EXLS vs RGEN Comparison

Compare EXLS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$29.89

Market Cap

5.1B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$110.07

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXLS
RGEN
Founded
1999
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
8.1B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
EXLS
RGEN
Price
$29.89
$110.07
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$46.80
$175.64
AVG Volume (30 Days)
2.0M
811.6K
Earning Date
04-28-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
286.96
EPS
1.54
0.86
Revenue
$2,087,679,000.00
$141,236,000.00
Revenue This Year
$12.66
$14.31
Revenue Next Year
$10.54
$14.41
P/E Ratio
$19.70
$132.98
Revenue Growth
13.56
35.10
52 Week Low
$26.94
$102.97
52 Week High
$48.79
$175.77

Technical Indicators

Market Signals
Indicator
EXLS
RGEN
Relative Strength Index (RSI) 38.15 30.20
Support Level $28.62 N/A
Resistance Level $31.50 $132.51
Average True Range (ATR) 0.93 4.68
MACD 0.15 0.43
Stochastic Oscillator 26.92 2.57

Price Performance

Historical Comparison
EXLS
RGEN

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: